CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 173 filers reported holding CLOVIS ONCOLOGY INC in Q2 2019. The put-call ratio across all filers is 0.27 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $13,000 | -95.6% | 250,200 | 0.0% | 0.00% | – |
| Q3 2022 | $298,000 | -33.8% | 250,200 | 0.0% | 0.00% | -100.0% |
| Q2 2022 | $450,000 | -16.8% | 250,200 | -6.7% | 0.00% | – |
| Q1 2022 | $541,000 | -25.5% | 268,062 | 0.0% | 0.00% | -100.0% |
| Q4 2021 | $726,000 | -39.3% | 268,062 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $1,196,000 | -17.9% | 268,062 | +6.8% | 0.00% | 0.0% |
| Q2 2021 | $1,456,000 | -17.4% | 251,053 | 0.0% | 0.00% | -50.0% |
| Q1 2021 | $1,762,000 | +46.0% | 251,053 | -0.2% | 0.00% | 0.0% |
| Q4 2020 | $1,207,000 | -17.7% | 251,458 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $1,466,000 | -13.6% | 251,458 | 0.0% | 0.00% | -33.3% |
| Q2 2020 | $1,697,000 | +166.4% | 251,458 | +151.0% | 0.00% | +200.0% |
| Q1 2020 | $637,000 | -39.0% | 100,200 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $1,045,000 | +165.2% | 100,200 | 0.0% | 0.00% | 0.0% |
| Q3 2019 | $394,000 | -91.2% | 100,200 | -66.7% | 0.00% | -66.7% |
| Q2 2019 | $4,470,000 | +79.7% | 300,600 | +200.0% | 0.00% | -25.0% |
| Q1 2019 | $2,487,000 | +38.2% | 100,200 | 0.0% | 0.00% | +33.3% |
| Q4 2018 | $1,800,000 | -93.0% | 100,200 | -88.6% | 0.00% | -92.9% |
| Q3 2018 | $25,802,000 | -17.9% | 878,530 | +27.1% | 0.04% | -22.2% |
| Q2 2018 | $31,441,000 | -3.3% | 691,459 | +12.3% | 0.05% | -8.5% |
| Q1 2018 | $32,518,000 | -8.1% | 615,870 | +18.4% | 0.06% | -6.3% |
| Q4 2017 | $35,372,000 | -18.5% | 520,171 | -1.3% | 0.06% | -19.2% |
| Q3 2017 | $43,415,000 | +37.3% | 526,880 | +56.0% | 0.08% | +34.5% |
| Q2 2017 | $31,616,000 | – | 337,669 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |